Program Book - Confex

5:20 pm
Fibrocytes in Autoimmune Fibroses
Erica Herzog, MD, PhD; Yale University School of Medicine; New
Haven, CT
Upon completion of this session, participants should be able to:
• identify current concepts of the immune pathogenesis of
interstitial lung diseases
• describe the role of fibrocytes in systemic fibroses and their
biomarker potential
• analyze the adaptive immune mechanisms that may govern
fibrogenesis
W196b
Osteoarthritis: A Disease of the Joint as an Organ R
Moderators: Richard F. Loeser, MD; Wake Forest University;
Winston-Salem, NC
Carla R. Scanzello, MD, PhD; Rush University Medical Center;
Chicago, IL
4:30 pm
How Understanding Joint Development Can Contribute to a
New Understanding of Osteoarthritis
Maurizio Pacifici, PhD; Children’s Hospital of Philadelphia;
Philadelphia, PA
4:55 pm
The Role of Synovial Inflammation in Osteoarthritis
Wim B. Van Den Berg, PhD; Radboud University Nijmegen Med
Centre; Nijmegen, Netherlands
5:20 pm
The Subchondral Bone and Osteoarthritis: Not Just Hard Tissue
Harrie Weinans, PhD; Erasmus Medical Center; Rotterdam,
Netherlands
Upon completion of this session, participants should be able to:
• recognize osteoarthritis as a condition of the entire joint as an
organ
• identify developmental processes within the joint that may
contribute to the development of osteoarthritis
• define the synovial changes that occur in osteoarthritis and
discuss how synovitis may contribute to disease progression
• relate the changes in the subchondral bone to joint tissue
changes in osteoarthritis
ACR CLINICAL SYMPOSIA
4:30 - 6:00 pm
W375c
Challenging Complications of Systemic Sclerosis C
cP
Moderators: Laura K. Hummers, MD, ScM; Johns Hopkins
University; Baltimore, MD
Victoria K. Shanmugam, MBBS, MRCP; Georgetown University
Hospital; Washington, DC
4:30 pm
Cardiac Involvement from Scleroderma
Yannick Allanore, MD, PhD; Paris Descartes University, Cochin
Hospital; Paris, France
4:55 pm
Gastrointestinal Involvement in Scleroderma
Romy Christmann, MD, PhD; Boston University; Boston, MA
5:20 pm
Scleroderma Associated Arthritis, Tendon Rubs, Neuropathy
and Vasculitis
Virginia D. Steen, MD; Georgetown University Medical Center;
Washington, DC
Upon completion of this session, participants should be able to:
• recognize the cardiac complications of scleroderma and the
current evidence to guide management of these complications
• recognize the gastrointestinal complications associated with
scleroderma and apply the current evidence to managing
patients with these complications
• discuss some of the challenging complications of scleroderma
including arthritis, tendon rubs, neuropathy and vasculitis
W190a
Developing ACR Guidelines for the Treatment of
Gout c/r PS
Moderators: Liana Fraenkel, MD, MPH; Yale University; New
Haven, CT
David A. Fox, MD; University of Michigan Medical Center; Ann
Arbor, MI
Speakers: John D. FitzGerald, MD, PhD; University of California
Los Angeles School Medical Rehabilitation; Los Angeles, CA
Puja Khanna, MD, MPH; University of Michigan; Ann Arbor, MI
Dinesh Khanna, MD, MSc; University of Michigan; Ann Arbor, MI
Robert Terkeltaub, MD; Veterans Affairs Medical Center; San
Diego, CA
Upon completion of this session, participants should be able to:
• explain the process used to develop gout treatment guidelines
• describe treatment guidelines for management of acute gouty
arthritis
• describe treatment for serum urate lowering therapy
• discuss treatment guidelines for management of chronic
tophaceous gout
W192b
Extra Glandular Manifestations of Sjögren’s Syndrome
C
Moderators: E. William St.Clair, MD; Duke University Medical
Center; Durham, NC
Mary E. Cronin, MD; Medical College of Wisconsin; Milwaukee,
WI
4:30 pm
The Nervous System and Sjögren’s Syndrome
Julius Birnbaum, MD, MHS; Johns Hopkins University; Baltimore,
MD
5:10 pm
Evidence to Support B Cell Therapy in Sjögren’s Syndrome
Xavier Mariette, MD; Université Paris-Sud; Le Kremlin Bicetre,
France
Upon completion of this session, participants should be able to:
• describe the diverse presentations of involvement of the
central nervous system in Sjögren’s syndrome
• describe the diagnostic approach to and manifestations of
small fiber neuropathy in Sjögren’s syndrome
TUESDAY
November 8, 2011
2011 Program Book 107